Multiple myeloma, or blood plasma cancer, is characterized by increased blood vessel formulation (angiogenesis) in the bone marrow that is a predictive factor in survival. One treatment approach used for multiple myeloma is stem cell transplantation with the patient's own stem cells. The following data (stored in Myeloma) represent the bone marrow microvessel density for patients who had a complete response to the stem cell transplant (as measured by blood and urine tests). The measurements were taken immediately prior to the stem cell transplant and at the time the complete response was determined.
a. At the 0.05 level of significance, is there evidence that the mean bone marrow microvessel density is higher before the stem cell transplant than after the stem cell transplant?
b. Interpret the meaning of the p-value in (a).
c. Construct and interpret a 95% confidence interval estimate of the mean difference in bone marrow microvessel density before and after the stem cell transplant.
d. What assumption is necessary about the population distribution in order to perform the test in (a)?

Transcribed Image Text:

e-44-7060 810297 \ 2212212 01 8 9 2 3 6 61 f-58051 24 ,112344 Pat 1234567